Harrow (HROW) Preferred Dividend Payments (2012 - 2021)

Harrow (HROW) posted quarterly Preferred Dividend Payments of $472000.0 for Q2 2021, up 136.0% quarter-over-quarter from $200000.0 in Q2 2012.

Harrow (HROW) Preferred Dividend Payments (2012 - 2021) Analysis & Trends

Harrow's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $472000.0 for Q2 2021.

In Q2 2021, Preferred Dividend Payments changed N/A year-over-year to $472000.0; the TTM figure through Dec 2021 stood at $472000.0 (changed N/A YoY), while the FY2021 annual figure was $472000.0, changed N/A from the prior year.
Preferred Dividend Payments for Q2 2021 stood at $472000.0, up from $200000.0 in the prior quarter.
The five-year high for Preferred Dividend Payments was $472000.0 in Q2 2021, with the low at $472000.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	43.08 Bn	39.43 Bn	2.15 Bn	-
3	Zoetis	31.54 Bn	29.87 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-
5	United Therapeutics	22.12 Bn	19.46 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.50 Bn	15.11 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Harrow	1.55 Bn	1.47 Bn	50.36 Mn	-

Download Data

Date	Value
Jun 30, 2021	472,000.00
Jun 30, 2012	200,000.00